TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome

Abstract

In this study, the prevalence of TP53 mutation in de novo AML and MDS-EB patients were low but it had impact on survival. Patients with monosomy or complex karyotype had more frequent TP53 mutation.